References
- Watts J A, Koch C D, LaNoue K F. Effects of calcium antagonism on energy metabolism: calcium and heart function after ischemia. Am J Physiol 1980; 238: H909–16
- Hamm C W, Opie L H. Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine, and dil-tiazem in the coronary-ligated, isolated working rat heart. Circ Res 1983; 52: 129–38
- Nayler W G, Ferrari R, Williams A. Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium. Am J Cardiol 1980; 46: 242–8
- Fleckenstein A. Calcium Antagonism in Heart and Smooth Muscle, Experimental Facts and Therapeutic Prospects. John Wiley and Sons, New York 1983
- Nayler W G, Szeto J. Effect of verapamil on contractility, oxygen utilization and calcium exchangeability in mammalian heart muscle. Car-diovasc Res 1972; 6: 120–8
- Jodalen H, Stangeland L, Grong K, Vik-Mo H, Lekven J. Lipid accumulation in the myocardium during acute regional ischemia in cats. J Mol Cell Cardiol 1985; 17: 973–80
- Bilheimer D W, Buja L M, Parkey R W, Bonte F J, Willerson J T. Fatty acid accumulation and abnormal lipid deposition in peripheral and border zones of experimental myocardial infarcts. J Nucl Med 1978, 19: 276–83
- Grong K, Jodalen H, Stangeland L, Vik-Mo H, Lekven J. Cellular lipid accumulation in different regions of myocardial infarcts in cats during betaadrenergic blocade with timolol. Cardiovasc Res 1986; 20: 248–55
- Jodalen H, Ytrehus K, Moen P, Hokland B, Mjøs O D. Oxfenicine-induced accumulation of lipid in the rat myocardium. J Mol Cell Cardiol 1988; 20: 277–82
- Lie R K, Jodalen H G, Rotevatn S. Accumulation of myocardial lipid droplets in dexamethasone-treated mice. Cell Tissue Res 1981; 216: 661–3
- Jodalen H G, Lie R, Rotevatn S. Effect of isoproterenol on lipid accumulation in myocardial cells. Res Exp Med 1982; 181: 239–44
- Schaper J. Structural characteristics in regional verus global ischemia. Adv Myocardial 1980; 2: 311–4
- Crass I MF, II. Myocardial triacylglycerol metabolism in ischemia. Tex Rep Biol Med 1979; 39: 439–52
- Bing R J, Weishaar R, Rackl A, Pavlik G. Antianginal drugs and cardiac metabolism. New Drug Therapy with a Calcium Antagonist, R J Bing. Excerpta Medica, Amsterdam 1979; 27–37, International Congress Series, no. 487
- Karnovsky M J. A formaldehyde-glutaraldehyde fixative of high osmolality for use in electron microscopy. J Cell Biol 1965; 27: 137A
- Heymann M A, Payne B D, Hoffman J IE, Rudolph A M. Blood flow measurements with radionuclide-labelled particles. Progr Cardiovasc Dis 1977; 20: 55–79
- Mayhew T M, Cruz Orive L-M. Caveat on the use of the Delesse principle of areal analysis for estimating component volume densities. J Mi-crosc 1974; 102: 195–207
- Bergmann S R, Carlson E, Dannen E, Sobel B E. An improved assay with 4-(2-thiazolylazo) resorcinol for non-esterified fatty acids in biological fluids. Clin Chem Acta 1980; 104: 53–63
- Wallenstein S, Zucker C L, Fleiss J L. Some statistical methods useful in circulation research. Circ Res 1980; 47: 1–9
- Zar J H. Biostatistical Analysis. Prentice-Hall, Englewood Cliffs, NJ 1974
- BMDP-Statistical Software. University of California Press, Los Angeles, CA 1983
- Pollard J HA. Handbook of Numerical and Statistical Techniques. Cambridge University Press, Cambridge 1979
- Vary T C, Reibel D K, Neely J R. Control of energy metabolism of heart muscle. Ann Rev Physiol 1981; 43: 419–30
- Kjekshus J K, Mjös O D. Effect of inhibition of lipolysis on infarct size after experimental coronary artery occlusion. J Clin Invest 1973; 52: 1770–8
- Vik-Mo H, Mjös O D, Neely J R, Maroko P R, Ribeiro L G. Limitation of myocardial infarct size by metabolic interventions that reduce accumulation of fatty acid metabolites in ischemic myocardium. Am Heart J 1986; 111: 1048–54
- Bielefeld D R, Vary C T, Neely J R. Inhibition of carnitine palmitoyl-CoA transferase activity and fatty acid oxydation by lactate and oxfenicine in cardiac muscle. J Mol Cell Cardiol 1985; 17: 619–25
- Thuesen L, Jørgensen J R, Kvistgaard H J, et al. Effect of verapamil on enzyme release after early intravenous administration in acute myocardial infarction: double blind randomized trial. Br Med J 1983; 286: 1107–8
- Lange R, Ingwall J, Hale S, Alker K J, Braunwald E, Kloner R A. Preservation of high-energy phosphates by verapamil in reperfused myocardium. Circulation 1984; 70: 734–41
- Kobayashi A, et al. Antiarrythmic and myocardial metabolic effects of verapamil during coronary artery reperfusion. Japanese Circulation Journal 1985; 49: 316–24